NCT07275190
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +18 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo, SC Reumatologia Pavia, Italy
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
NCT06251076
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT06803693
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China
Recruiting
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
NCT07270835
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07268846
- Conditions
- Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +33 more
- Locations
-
- A.C.Camargo Cancer Center São Paulo, Brazil
NCT05556928
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +19 more
- Locations
-
- Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
Recruiting
Registry of the German CLL Study Group
NCT02863692
- Conditions
- CLL, HCL, Hematologic Diseases, +19 more
- Locations
-
- BAG Freiberg-Richter, Jacobasch, Wolf, Illmer Dresden, Saxony, Germany
NCT07270679
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
NCT06421948
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
- Liling Zhang Wuhan, Hubei, China
- Yajun Li Changsha, Hunan, China
- Ming Jiang Chengdu, Sichuan, China
Recruiting
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
NCT04925609
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Granuloma, Granuloma, Plasma Cell, +15 more
- Locations
-
- Institut Gustave Roussy Paris, France
- Princess Máxima Center for Pediatric Oncology Utrecht, Netherlands